All posts by: Michael Zand

About Michael Zand

Th17 cells could facilitate wider clinical use of adoptive immunotherapy – Medical Xpress

Continue reading

2017-04-14 NEWS

Medical Xpress

Th17 cells could facilitate wider clinical use of adoptive immunotherapy
Medical Xpress
Medical University of South Carolina (MUSC) investigators report that long-term expansion protocols for adoptive cancer immunotherapy do not compromise Th17 cells’ effectiveness against large tumors, in the March 9, 2017 issue of JCI Insight. This

and more »

Continue reading

2017-04-14 NEWS

EurekAlert (press release)

Th17 cells could facilitate wider clinical use of adoptive immunotherapy
EurekAlert (press release)
Medical University of South Carolina (MUSC) investigators report that long-term expansion protocols for adoptive cancer immunotherapy do not compromise Th17 cells’ effectiveness against large tumors, in the March 9, 2017 issue of JCI Insight. This

and more »

Continue reading

2017-04-14 NEWS

Genetic Engineering & Biotechnology News

Inflammation-Sensing Gut Bacteria Brought to You by Synthetic Biology
Genetic Engineering & Biotechnology News
New research may eventually lead to orally ingestible bacteria for monitoring gut health and disease—with the ultimate goal being the development of a home inflammation test. Listen now for more details!

Continue reading

2017-04-14 NEWS

Fred Hutch News Service

Good News at Fred Hutch
Fred Hutch News Service
The Bezos Family Immunotherapy Clinic — which officially opened last fall at Seattle Cancer Care Alliance and is named in recognition of the Bezos family’s commitment to immunotherapy research at Fred Hutchinson Cancer Research Center — has been …

Continue reading

2017-04-14 NEWS

Fred Hutch News Service

Good News at Fred Hutch
Fred Hutch News Service
The Bezos Family Immunotherapy Clinic — which officially opened last fall at Seattle Cancer Care Alliance and is named in recognition of the Bezos family’s commitment to immunotherapy research at Fred Hutchinson Cancer Research Center — has been …

Continue reading

2017-04-14 NEWS

Science Daily

Gene-editing alternative corrects Duchenne muscular dystrophy
Science Daily
“By either skipping a mutation region or precisely repairing a mutation in the gene, CRISPRCpf1-mediated genome editing not only corrects Duchenne muscular dystrophy mutations but also improves muscle contractility and strength,” said co-author Dr.

and more »